This means that Nucleus 22 Implant recipients can now upgrade to Cochlear’s latest behind-the-ear sound processor, and, “for the first time, benefit from the smallest and lightest behind-the-ear sound processor 1 with direct smartphone connectivity and streaming.” The Nucleus 7 Sound Processor is now compatible with a Nucleus 22 Implant. Nucleus 7 Sound Processor for Nucleus 22 Implant recipients The Kanso 2 Sound Processor features a simple, durable, all-in-one design that makes it easy to use with button-free control and an automatic on/off function.Īt commercial availability, the Kanso 2 Sound Processor is compatible with Cochlear N24, CI24RE, CI500, Profile, ® and Profile Plus Series Implants. To help users hear more of what they want to listen to, the Kanso 2 Sound Processor includes Cochlear’s proven hearing performance technologies 3-6 of dual microphones, ForwardFocus, ¥ and SmartSound ® IQ with SCAN**. The Kanso 2 Sound Processor features “a simple, durable all-in-one design that makes it easy to use.” Button-free control with an automatic on/off function helps to simplify the experience particularly for children or people with poor dexterity. The Kanso 2 Sound Processor also features “the highest possible water resistance rating † for any off-the-ear cochlear implant sound processor, giving users the freedom to live an active lifestyle.” The Kanso 2 Sound Processor features new charging options, including the sound processor’s built-in rechargeable battery 2 all-in-one Home Charger, allowing charging, drying, and storing of the sound processor at the same time and a small, optional portable charger for on-the-go use. The Kanso 2 Sound Processor is “the world’s smallest off-the-ear cochlear implant sound processor.” It is also compatible with the Nucleus Smart App, enabling control of device settings, hearing functions, and information.* The Kanso 2 Sound Processor is reportedly the world’s smallest 1 off-the-ear cochlear implant sound processor, and it is the first and only off-the-ear cochlear implant sound processor to offer direct streaming from compatible Apple ® or Android™ devices,* according to Cochlear. “Our new technology can better meet the individual needs and lifestyles of our recipients and is the result of persistent efforts to improve hearing outcomes.” “Cochlear continues to develop and introduce products to support the best lifelong hearing experience for our recipients and their care team,” said Tony Manna, President, Cochlear Americas. The approval of the Cochlear TM Nucleus ® Kanso ® 2 Sound Processor, Nucleus ® 7 Sound Processor for Nucleus 22 Implant recipients, and Custom Sound ® Pro fitting software reflects Cochlear’s “ongoing commitment to innovation in hearing technology, providing access to smartphone connectivity and helping to improve hearing performance, and enhancing the cochlear implant fitting experience for hearing health professionals.” Cochlear Limited (ASX:COH) announced the US Food and Drug Administration (FDA) approval of three new products to its suite of hearing technology solutions.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |